Recombinant Human GPD1L Protein，His

GPD1L (Glycerol-3-Phosphate Dehydrogenase 1-Like) is an enzyme that plays a crucial role in lipid metabolism and energy production within cells. It is primarily involved in the conversion of glycerol-3-phosphate to dihydroxyacetone phosphate, thus participating in the glycerol phosphate shuttle, which is essential for the transport of electrons into the mitochondria for ATP synthesis. Recent studies have highlighted the significance of GPD1L in various physiological processes, including cardiac function and metabolic regulation. Mutations in the GPD1L gene have been associated with cardiac arrhythmias and other cardiovascular diseases, making it a key target for research in understanding the molecular mechanisms underlying these conditions. Additionally, the protein's involvement in the pathophysiology of metabolic disorders has opened avenues for exploring therapeutic interventions that could modulate its activity. The development of recombinant GPD1L proteins for experimental purposes has enabled researchers to investigate the functional properties of this enzyme in greater detail, contributing to our understanding of its role in metabolism and disease. As the global prevalence of metabolic syndromes and cardiovascular issues continues to rise, understanding the function and regulation of GPD1L could potentially yield novel insights into prevention and treatment strategies.  Researchers are increasingly focusing on characterizing its biochemical properties, exploring its potential as a biomarker, and investigating the therapeutic implications of modulating its activity in various disease contexts. These efforts aim to unravel the complexities of GPD1L's role within the broader network of metabolic regulation and its potential impact on human health.